Literature DB >> 11079031

Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).

C Röcken1, M Pross, U Brucks, K Ridwelski, A Roessner.   

Abstract

A 59-year-old woman presented with epigastric pain and weight loss. Ultrasound, computed tomography, and magnetic resonance imaging scans of the abdomen showed a tumor in segments 6 and 7 of the right liver lobe, measuring 8 cm in greatest diameter. The tumor was subsequently resected, and histopathology showed a poorly differentiated adenocarcinoma immunoreactive for CA 19-9 and cytokeratin 19. In the absence of any other clinically detectable primary tumor, the lesion was diagnosed as a peripheral intrahepatic cholangiocarcinoma. In addition, multiple bile duct hamartomas were found in the surrounding parenchyma. The tumor was unrelated to Caroli disease, primary sclerosing cholangitis, ulcerative colitis, or nonbiliary cirrhosis, as demonstrated by further clinical and histopathologic investigations, but probably was associated with the presence of multiple bile duct hamartomas. To our knowledge, this is the eighth reported case of a cholangiocarcinoma associated with multiple bile duct hamartomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079031     DOI: 10.5858/2000-124-1704-COIALW

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Multiple bile duct hamartomas mimicking diffuse hepatic metastasis: GI image.

Authors:  Ashish Singhal; Rajesh Kanagala; Harlan I Wright; Vivek Kohli
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

2.  Bile Duct Hamartoma Mimicking Metastatic Cholangiocarcinoma.

Authors:  Raymond Elsoueidi; Stephen J Mularz; Elie M Richa
Journal:  J Gastrointest Cancer       Date:  2017-03

Review 3.  Multiple von Meyenburg complexes mimicking diffuse liver metastases from esophageal squamous cell carcinoma.

Authors:  Stefan Fritz; Thilo Hackert; Hendrik Blaker; Werner Hartwig; Lutz Schneider; Markus-W Buchler; Jens Werner
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

4.  Imaging analysis of the malignant transformation of bile duct hamartomas in the liver: A case report and literature review.

Authors:  Yuan Yuan; Gang Fu; Feng Wan; Xu-Lei Chen; Jun Feng
Journal:  Exp Ther Med       Date:  2022-05-09       Impact factor: 2.751

5.  Extra-hepatic bile duct hamartoma in a 10-month-old with a morgagni hernia and multiple anatomical anomalies: a rare and incidental finding.

Authors:  Adil A Shah; Michael Karass; Andrew J Page; Bahig M Shehata; Megan M Durham
Journal:  Pediatr Surg Int       Date:  2013-03-02       Impact factor: 1.827

6.  Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Authors:  Mark Ettel; Ogechukwu Eze; Ruliang Xu
Journal:  World J Hepatol       Date:  2015-11-08

7.  Rare liver tumor: symptomatic giant von Meyenburg complex.

Authors:  Yardesh Singh; Shamir O Cawich; Chunilal Ramjit; Vijay Naraynsingh
Journal:  J Surg Case Rep       Date:  2017-01-09

8.  Hepatic von Meyenburg complex: a trigger of severe portal hypertension.

Authors:  Shuhei Yoshida; Kazutaka Kurokohchi; Takuya Ueno; Morihiko Yoshino; Masahiko Shimada; Tsutomu Masaki
Journal:  Liver Int       Date:  2008-10-14       Impact factor: 5.828

Review 9.  Benign biliary neoplasms and biliary tumor precursors.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Claudia Covelli; Paola Capelli; Alberto Furlanetto; Maria Guido
Journal:  Pathologica       Date:  2021-06

10.  Pediatric living donor liver transplantation for congenital hepatic fibrosis using a mother's graft with von Meyenburg complex: A case report.

Authors:  Naoya Yamada; Yukihiro Sanada; Takumi Katano; Masahisa Tashiro; Yuta Hirata; Noriki Okada; Yoshiyuki Ihara; Atsushi Miki; Hideki Sasanuma; Taizen Urahashi; Yasunaru Sakuma; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.